PWA
RGNX icon

Physician Wealth Advisors’s Regenxbio RGNX Stock Holding History

Physician Wealth Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-113
Closed -$1.63K – 2206
2025
Q4 		$1.63K Hold
113
– – ﹤0.01% 1382
2025
Q3 		$1.09K Hold
113
– – ﹤0.01% 1524
2025
Q2 		$928 Buy
+113
New +$946 ﹤0.01% 1484

Other funds holding RGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Physician Wealth Advisors's RGNX Position: Q1 2026 in Review

Physician Wealth Advisors sold out of Regenxbio (RGNX) in Q1 2026, closing a stake of 113 shares — an estimated $1.63K sold.

Physician Wealth Advisors first reported a position in RGNX in Q2 2025 and held it in 3 quarters. The position peaked at $1.63K in Q4 2025. 178 funds tracked by Wall St. Rank hold RGNX as of Q1 2026.

  • Physician Wealth Advisors reported no remaining Regenxbio position as of Q1 2026 after selling out during the quarter.
  • Physician Wealth Advisors sold 113 Regenxbio shares in Q1 2026, an estimated $1.63K.
  • Physician Wealth Advisors first reported a position in Regenxbio in Q2 2025 and held it in 3 quarters.
  • Physician Wealth Advisors's Regenxbio position peaked at $1.63K in Q4 2025.
  • 178 funds tracked by Wall St. Rank held Regenxbio as of Q1 2026.

Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.